ArticleThe Journal of clinical investigation2013

CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling.

Katrin Faber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.